| [1] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
| [2] |
World Health Organization. Definitions and reporting framework for tuberculosis 2013 revision. Geneva: World Health Organization, 2013.
|
| [3] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
|
| [4] |
翁心华. 评分子生物学技术在感染性疾病检测中的评价. 诊断学理论与实践, 2004, 3(1): 1-2. doi: 10.3969/j.issn.1671-2870.2004.01.001.
doi: 10.3969/j.issn.1671-2870.2004.01.001
|
| [5] |
卢洪洲, 汤一苇. 感染性疾病的基因诊断. 国外医学(流行病学.传染病学分册), 2002, 29(5): 257-259. doi: 10.3760/cma.j.issn.1673-4149.2002.05.001.
doi: 10.3760/cma.j.issn.1673-4149.2002.05.001
|
| [6] |
鲁辛辛. 我国分子生物学技术在临床微生物检测中的若干问题. 中华检验医学杂志, 2005, 28(5): 468-471. doi: 10.3760/j:issn:1009-9158.2005.05.002.
doi: 10.3760/j:issn:1009-9158.2005.05.002
|
| [7] |
谭守勇. 分子生物学检测在肺结核病精准诊断中的应用. 广东医学, 2021, 42(4): 373-376. doi: 10.13820/j.cnki.gdyx.20210492.
doi: 10.13820/j.cnki.gdyx.20210492
|
| [8] |
MacLean E, Kohli M, Weber SF, et al. Advances in Molecular Diagnosis of Tuberculosis. J Clin Microbiol, 2020, 58(10): e01582-19. doi: 10.1128/JCM.01582-19.
doi: 10.1128/JCM.01582-19
|
| [9] |
Machado D, Couto I, Viveiros M. Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infect Genet Evol, 2019, 72: 93-112. doi: 10.1016/j.meegid.2018.11.021.
doi: S1567-1348(18)30933-X
pmid: 30508687
|
| [10] |
Steingart KR, Schiller I, Horne DJ, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 2014, 2014(1): CD009593. doi: 10.1002/14651858.CD009593.pub3.
doi: 10.1002/14651858.CD009593.pub3
|
| [11] |
Nagai K, Horita N, Yamamoto M, et al. Diagnostic test accuracy of loop-mediated isothermal amplification assay for Mycobacterium tuberculosis: systematic review and meta-analysis. Sci Rep, 2016, 6: 39090. doi: 10.1038/srep39090.
doi: 10.1038/srep39090
URL
|
| [12] |
Yu G, Shen Y, Zhong F, et al. Diagnostic accuracy of the loop-mediated isothermal amplification assay for extrapulmonary tuberculosis: A meta-analysis. PLoS One, 2018, 13(6): e0199290. doi: 10.1371/journal.pone.0199290.
doi: 10.1371/journal.pone.0199290
URL
|
| [13] |
Zhou X, Wu H, Ruan Q, et al. Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Metagenomic Next-Generation Sequencing of Direct Clinical Samples. Front Cell Infect Microbiol, 2019, 9: 351. doi: 10.3389/fcimb.2019.00351.
doi: 10.3389/fcimb.2019.00351
URL
|
| [14] |
Marlowe EM, Novak-Weekley SM, Cumpio J, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol, 2011, 49(4): 1621-1623. doi: 10.1128/JCM.02214-10.
doi: 10.1128/JCM.02214-10
URL
|
| [15] |
Singh A, Kashyap VK. Specific and Rapid Detection of Mycobacterium tuberculosis Complex in Clinical Samples by Polymerase Chain Reaction. Interdiscip Perspect Infect Dis, 2012, 2012: 654694. doi: 10.1155/2012/654694.
doi: 10.1155/2012/654694
|
| [16] |
World Health Organization. WHO consolidated guidelines on tuberculosis.Module 3:diagnosis-rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization, 2021.
|
| [17] |
中华医学会结核病学分会临床检验专业委员会. 结核病病原学分子诊断专家共识. 中华结核和呼吸杂志, 2018, 41(9): 688-695. doi: 10.3760/cma.j.issn.1001-0939.2018.09.008.
doi: 10.3760/cma.j.issn.1001-0939.2018.09.008
|
| [18] |
中华医学会检验医学分会. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识. 中华检验医学杂志, 2020, 43(12): 1181-1195. doi: 10.3760/cma.j.cn114452-20200903-00704.
doi: 10.3760/cma.j.cn114452-20200903-00704
|
| [19] |
王黎霞. 结核病防治可持续发展之路——回顾“十三五”展望“十四五”. 中国防痨杂志, 2021, 43(1): 3-5. doi: 10.3969/j.issn.1000-6621.2021.01.002.
doi: 10.3969/j.issn.1000-6621.2021.01.002
|
)
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
